Advances in Alzheimer’s and Parkinson’s Disease Insights, Progress, and Perspectives /
Proceedings of the 7th International Conference on Alzheimer’s Disease and Parkinson’s Disease (ADPD), held March 9-13, 2005 in Sorrento, Italy. The subject matter of the ADPD conferences is unique in that it deals not only with issues related individually to Alzheimer’s disease and Parkinson’s dise...
| Συγγραφή απο Οργανισμό/Αρχή: | |
|---|---|
| Άλλοι συγγραφείς: | , , , |
| Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
| Γλώσσα: | English |
| Έκδοση: |
Boston, MA :
Springer US,
2008.
|
| Σειρά: | Advances in Behavioral Biology ;
57 |
| Θέματα: | |
| Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- Clinical Features and Treatment of Dementia Associated With Parkinson’s Disease
- Neurogenetics in Parkinson's Disease
- Impaired DNA Repair Systems: Generation of Mitochondrial Dysfunction and Increased Sensitivity to Excitotoxicity
- Current Problems and Strategies in Motor Rehabilitation for Parkinson’s Disease
- Critical Acute Akinesia in Parkinson’s Disease Patients Concomitant with Additional Precipitating Factors Other Than Treatment Withdrawal: A Possible Lethal Complication
- Biomarkers for Early Detection of Parkinson’s Disease: An Essential Challenge
- Neurotransmitter and Neurotrophic Factor-Secreting Cell Line Grafting for the Treatment of Parkinson’s Disease
- Novel Therapeutic Target in PD: Experimental Models
- LRRK2 (Leucine-Rich Repeat Kinase 2) Gene on PARK8 Locus in Families with Parkinsonism
- Microglia Activation and Gene Expression of Cytokines in Parkinson’s Disease
- Dissecting the Biochemical Pathways Mediated by Genes Implicated in Parkinson’s Disease: Induction of DJ-1 Expression in A30P ?-Synuclein Mice
- Neuroinflammation in Early Stages of Alzheimer’s Disease and Parkinson’s Disease
- Alzheimer’s Disease, Parkinson’s Disease, and Frontotemporal Dementias: Different Manifestations of Protein Misfolding
- Role of Oxidative Insult and Neuronal Survival in Alzheimer’s and Parkinson’s Diseases
- Redox Proteomics Identification of Oxidatively Modified Proteins in Alzheimer’s Disease Brain and in Brain from a Rodent Model of Familial Parkinson’s Disease: Insights into Potential Mechanisms of Neurodegeneration
- Biomarkers for Alzheimer’s Disease and Parkinson’s Disease
- Bioluminescent Imaging of Excitotoxic and Endotoxic Brain Injury in Living Mice
- Alzheimer’s Disease Neuroimaging Initiative
- Two Hits and You’re Out? A Novel Mechanistic Hypothesis of Alzheimer Disease
- Vascular Risk Factors and Risk for Alzheimer’s Disease and Mild Cognitive Impairment: Population-Based Studies
- Cholesterol Transport and Production in Alzheimer’s Disease
- Cholesterol and A? Production: Methods for Analysis of Altered Cholesterol De Novo Synthesis
- Glycosaminoglycans and Analogs in Neurodegenerative Disorders
- Prospective Role of Glycosaminoglycans in Apoptosis Associated with Neurodegenerative Disorders
- Stem Cell Therapy in Alzheimer’s Disease
- Oral A? Vaccine Using a Recombinant Adeno-Associated Virus Vector in an Alzheimer’s Disease Mouse Model
- In Vivo Targeting of Amyloid Plaques Via Intranasal Administration of Phage Anti-?-Amyloid Antibodies
- Decreased ProBDNF: The Cause of Alzheimer’s-Associated Neurodegeneration and Cognitive Decline?
- Shift in the Balance of TRKA and ProNGF in Prodromal Alzheimer ’s Disease
- Neuroprotective Effects of Trophic Factors and Natural Products: Involvement of Multiple Intracellular Kinases
- Intraneuronal A? and Alzheimer’s Disease
- Physiological Processing of the Cellular Prion Protein and ?APP: Enzymes and Regulation
- Expression of Wnt Receptors, Frizzled, in Rat Neuronal Cells
- Cell Models of Tauopathy
- Co-expression of FTDP-17 Human Tau and GSK-3ß (or APPSW) in Transgenic Mice: Induction of Tau Polymerization and Neurodegeneration
- Enhanced Activation of NF-?B Signaling by Apolipoprotein E4
- Pleiotropic Effects of Apolipoprotein E in Dementia: Influence on Functional Genomics and Pharmacogenetics
- Up-regulation of the ?-Secretase Pathway
- Frequency and Relation of Argyrophilic Grain Disease and Thorn-Shaped Astrocytes in Alzheimer’s Disease
- Cellular Membranes as Targets in Amyloid Oligomer Disease Pathogenesis
- Ganglioside-Dependent Generation of a Seed for Alzheimer’s Disease Amyloid
- Evidence That Amyloid Pathology Progresses in a Neurotransmitter-Specific Manner
- Rationale for Glutamatergic and Cholinergic Approaches for the Treatment of Alzheimer’s Disease
- Cortical Cholinergic Lesion Causes A? Deposition: Cholinergic-Amyloid Fusion Hypothesis
- Expression of Acetylcholinesterase in Alzheimer’s Disease Brain: Role in Neuritic Dystrophy and Synaptic Scaling
- Role of b-Amyloid in the Pathophysiology of Alzheimer’s Disease and Cholinesterase Inhibition: Facing the Biological Complexity to Treat the Disease
- Dissociation Between the Potent ?-Amyloid Protein Pathway Inhibition and Cholinergic Actions of the Alzheimer Drug Candidates Phenserine and Cymserine
- Allosteric Potentiators of Neuronal Nicotinic Cholinergic Receptors: Potential Treatments for Neurodegenerative Disorders.
